Allergy Research Unit, Kingston Health Sciences Center-KGH Site, Kingston, Ontario, Canada; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Allergy Research Unit, Kingston Health Sciences Center-KGH Site, Kingston, Ontario, Canada; Department of Medicine, Queen's University, Kingston, Ontario, Canada; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Ann Allergy Asthma Immunol. 2022 Jul;129(1):52-61. doi: 10.1016/j.anai.2021.12.013. Epub 2021 Dec 29.
To summarize the current literature of the psychological impacts of coronavirus disease 2019 (COVID-19) on people with allergic diseases and to identify gaps in need of future research.
Ovid MEDLINE(R) and Embase Classics + Embase from 1947 to present (October 18, 2021) were searched using a search strategy that included the following keywords: allergic diseases, covid*, and psychological disorders.
Primary manuscripts and abstracts using online and telephone surveys, mixed-method studies capturing patient and caregiver experiences, case studies, and published guidelines from allergic disease-specific expert groups were included.
People with asthma and other chronic respiratory conditions are at higher risk of negative psychological outcomes, and risk factors include asthma severity, female sex, and previous history of anxiety and depression, likely owing to the perceived risk of severe disease from COVID-19. One study identified that people with allergic rhinitis had significantly high anxiety and depression scores compared with healthy controls (both, P < .001). The psychological impacts of food allergy during COVID-19 were most strongly felt by parents and caregivers. Similarly, parents of children with asthma experienced substantial psychological burden.
COVID-19 had a considerable psychological impact on patients with asthma. Limited data have been published on the mental health impacts of COVID-19 on patients with allergic rhinitis and food allergy. As COVID-19 research continues to evolve and the literature captures later stages of the pandemic, it is important that physicians be aware of the potential coincidence of mental illness and chronic allergic diseases and refer these patients, and their caregivers, to appropriate resources while also continuing to manage their allergic disease(s).
总结目前关于冠状病毒病 2019(COVID-19)对过敏性疾病患者心理影响的文献,并确定未来研究的空白点。
从 1947 年至今(2021 年 10 月 18 日),使用包含以下关键词的搜索策略,在 Ovid MEDLINE(R) 和 Embase Classics+Embase 中进行了检索:过敏性疾病、covid*和心理障碍。
纳入了使用在线和电话调查的主要手稿和摘要、混合方法研究,以捕捉患者和照顾者的经验、病例研究以及过敏专科专家组发布的指南。
哮喘和其他慢性呼吸系统疾病患者发生负面心理结果的风险较高,风险因素包括哮喘严重程度、女性和以前的焦虑和抑郁史,这可能是由于 COVID-19 疾病严重程度的感知风险所致。一项研究发现,与健康对照组相比,过敏性鼻炎患者的焦虑和抑郁评分显著升高(均 P<.001)。COVID-19 期间食物过敏对父母和照顾者的心理影响最大。同样,哮喘儿童的父母也经历了巨大的心理负担。
COVID-19 对哮喘患者的心理健康产生了相当大的影响。关于 COVID-19 对过敏性鼻炎和食物过敏患者心理健康影响的文献有限。随着 COVID-19 研究的不断发展和文献对大流行后期的不断捕捉,医生应该意识到同时患有精神疾病和慢性过敏性疾病的潜在可能性,并在管理这些患者及其照顾者的过敏性疾病的同时,将这些患者及其照顾者转介给适当的资源。